Instrumento Inactivo

Otros idiomas Cellectar Biosciences Inc Nasdaq

Acciones

US15117F3029

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Cellectar Biosciences, Inc.(NasdaqCM:CLRB) added to Russell 3000E Index	01/07
Cellectar Biosciences, Inc.(NasdaqCM:CLRB) added to Russell Microcap Index	01/07
Cellectar Biosciences, Inc.(NasdaqCM:CLRB) added to Russell Microcap Growth Index	01/07
Cellectar Biosciences, Inc.(NasdaqCM:CLRB) added to Russell 3000E Growth Index	01/07
Cellectar Biosciences, Inc.(NasdaqCM:CLRB) added to Russell Microcap Value Index	01/07
Cellectar Biosciences, Inc.(NasdaqCM:CLRB) added to Russell 3000E Value Index	01/07
Cellectar Biosciences to Host Key Opinion Leader Event to Review the Full Results from Its CLOVER WaM Pivotal Trial and Waldenstrom's Macroglobulinemia Market Landscape	28/06
Cellectar Biosciences to Host Key Opinion Leader Event to Review the Full Results from Its CLOVER WaM Pivotal Trial and Waldenstrom’s Macroglobulinemia Market Landscape	27/06
Cellectar Biosciences and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis Fungoides	29/05
Cellectar Biosciences, Inc. and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis fungoides	29/05
Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate Update	14/05
Cellectar Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
Cellectar Biosciences to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day	08/05
Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, May 14, 2024	07/05
Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update	27/03
Cellectar Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Cellectar Biosciences to Announce 2023 Year End Earnings Results and Host a Conference Call on Wednesday, March 27, 2024	20/03
Cellectar Biosciences : Corporate Presentation - March 2024	18/03
Cellectar Biosciences to Present at the 36th Annual Roth Conference	14/03
Cellectar Biosciences Reports High Rate of Complete Remission in Investigator Initiated Phase I Study of Iopofosine in Combination with External Beam Radiotherapy in Recurrent Head and Neck Cancer	04/03

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Cellectar Biosciences Inc Nasdaq

Acciones

US15117F3029

Otros idiomas

Filtros